Chan SH - Search Results

1

Clinical significance of allelotype profiling for urothelial carcinoma.

Tzai TS, Chen HH, Chan SH, Ho CL, Tsai YS, Cheng HL, Dai YC, Lin JS, Yang WH, Chow NH. Tzai TS, et al. Among authors: chan sh. Urology. 2003 Aug;62(2):378-84. doi: 10.1016/s0090-4295(03)00344-3. Urology. 2003. PMID: 12893368

2

Overexpression of c-met as a prognostic indicator for transitional cell carcinoma of the urinary bladder: a comparison with p53 nuclear accumulation.

Cheng HL, Trink B, Tzai TS, Liu HS, Chan SH, Ho CL, Sidransky D, Chow NH. Cheng HL, et al. Among authors: chan sh. J Clin Oncol. 2002 Mar 15;20(6):1544-50. doi: 10.1200/JCO.2002.20.6.1544. J Clin Oncol. 2002. PMID: 11896103

3

Prognostic significance of proliferating cell nuclear antigen expression in transitional cell carcinoma of the upper urinary tract.

Cheng HL, Chow NH, Tzai TS, Tong YC, Lin JS, Chan SH, Yang WH, Chang CC, Lin YM. Cheng HL, et al. Among authors: chan sh. Anticancer Res. 1997 Jul-Aug;17(4A):2789-93. Anticancer Res. 1997. PMID: 9252716

4

Expression profiles of ErbB family receptors and prognosis in primary transitional cell carcinoma of the urinary bladder.

Chow NH, Chan SH, Tzai TS, Ho CL, Liu HS. Chow NH, et al. Among authors: chan sh. Clin Cancer Res. 2001 Jul;7(7):1957-62. Clin Cancer Res. 2001. PMID: 11448910

5

Significance of urinary epidermal growth factor and its receptor expression in human bladder cancer.

Chow NH, Liu HS, Lee EI, Chang CJ, Chan SH, Cheng HL, Tzai TS, Lin JS. Chow NH, et al. Among authors: chan sh. Anticancer Res. 1997 Mar-Apr;17(2B):1293-6. Anticancer Res. 1997. PMID: 9137488

6

Reappraisal of the biological role of epidermal growth factor receptor in transitional cell carcinoma.

Chow NH, Tzai TS, Lin SN, Chan SH, Tang MJ. Chow NH, et al. Among authors: chan sh. Eur Urol. 1993;24(1):140-3. doi: 10.1159/000474281. Eur Urol. 1993. PMID: 8365434

7

Significance of urinary tissue polypeptide specific antigen (TPS) determination in patients with urothelial carcinoma.

Yao WJ, Chang CJ, Chan SH, Chow NH, Cheng HL, Tzai TS, Lin SN. Yao WJ, et al. Among authors: chan sh. Anticancer Res. 1995 Nov-Dec;15(6B):2819-23. Anticancer Res. 1995. PMID: 8669871

8

Implications of urinary basic fibroblast growth factor excretion in patients with urothelial carcinoma.

Chow NH, Chang CJ, Yeh TM, Chan SH, Tzai TS, Lin JS. Chow NH, et al. Among authors: chan sh. Clin Sci (Lond). 1996 Feb;90(2):127-33. doi: 10.1042/cs0900127. Clin Sci (Lond). 1996. PMID: 8829882

9

The significance of prohibitin and c-Met/hepatocyte growth factor receptor in the progression of cervical adenocarcinoma.

Tsai HW, Chow NH, Lin CP, Chan SH, Chou CY, Ho CL. Tsai HW, et al. Among authors: chan sh. Hum Pathol. 2006 Feb;37(2):198-204. doi: 10.1016/j.humpath.2005.10.012. Epub 2005 Dec 20. Hum Pathol. 2006. PMID: 16426920

10

Prohibitin in the pathogenesis of transitional cell bladder cancer.

Wu TF, Wu H, Wang YW, Chang TY, Chan SH, Lin YP, Liu HS, Chow NH. Wu TF, et al. Among authors: chan sh. Anticancer Res. 2007 Mar-Apr;27(2):895-900. Anticancer Res. 2007. PMID: 17465217 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,079 results

Search Page

Filters